Wockhardt · NSE: WOCKPHARMA · BSE: 532300
Q2 FY24 results · Jul–Sep 2023
Wockhardt reported revenue from operations of ₹753.00 crore (up 10.9% from Q2 FY23) and net loss of ₹73.00 crore for Q2 FY24 (Jul–Sep 2023), on a consolidated basis.
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 753.00 | 679.00 | +10.9% | 644.00 | +16.9% |
| Other income | 24.00 | 57.00 | −57.9% | 14.00 | +71.4% |
| Total income | 777.00 | 736.00 | +5.6% | 658.00 | +18.1% |
| Profit before tax | (35.00) | (230.00) | Loss narrowed | (118.00) | Loss narrowed |
| Net profit for the period | (73.00) | (207.00) | Loss narrowed | (136.00) | Loss narrowed |
| Attributable to shareholders of the company | (77.00) | (189.00) | Loss narrowed | (134.00) | Loss narrowed |
| EPS, basic (₹) | (5.37) | (13.15) | Loss narrowed | (9.28) | Loss narrowed |
| Net margin (%) | -9.7 | -30.5 | -21.1 |
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 260.00 | 258.00 | +0.8% | 251.00 | +3.6% |
| Other income | 6.00 | 29.00 | −79.3% | 6.00 | +0.0% |
| Total income | 266.00 | 287.00 | −7.3% | 257.00 | +3.5% |
| Profit before tax | (107.00) | (115.00) | Loss narrowed | (115.00) | Loss narrowed |
| Net profit for the period | (107.00) | (75.00) | Loss widened | (115.00) | Loss narrowed |
| EPS, basic (₹) | (7.39) | (5.17) | Loss widened | (8.01) | Loss narrowed |
| Net margin (%) | -41.2 | -29.1 | -45.8 |
Consolidated
- Filed with BSE
- 15 Nov 2023, 17:19 IST
- Board meeting
- 14 Nov 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 15 Nov 2023, 17:19 IST
- Board meeting
- 14 Nov 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE